Form 4 Tracker
BridgeBio Pharma, Inc.
BBIO

45 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2026Mar 6 9:57 PMAndrea EllisDirector
Sale
64,921$64.87$4.2M18,589(D)

View →

Mar 4, 2026Mar 4 9:17 PMANDREA ELLIS
Proposed Sale
64,921$64.87$4.2M—

View →

Feb 27, 2026Mar 3 9:17 PMHannah ValantineDirector
Sale
25,484$67.41$1.7M7,465(D)

View →

Feb 27, 2026Feb 27 9:20 PMHANNAH A VALANTINE
Proposed Sale
25,484$67.41$1.7M—

View →

Feb 26, 2026Feb 27 9:11 PMMaricel ApuliChief Accounting Officer
Sale
2,000$66.00$132.0K121,945(D)

View →

Feb 19, 2026Feb 23 9:32 PMNeil KumarDirector, Chief Executive Officer
Sale
28,053$71.39$2.0M234,451(D)

View →

Feb 19, 2026Feb 19 9:22 PMNEIL KUMAR
Proposed Sale
28,053$73.93$2.1M—

View →

Feb 17, 2026Feb 18 11:39 PMMaricel ApuliChief Accounting Officer
Sale
510$74.31$37.9K123,945(D)

View →

Feb 17, 2026Feb 18 11:36 PMThomas TrimarchiPresident and CFO
Sale
13,600$74.72$1.0M336,585(D)

View →

Feb 17, 2026Feb 18 11:34 PMRandal W. ScottDirector
Sale
10,000$75.46$754.6K11,589(D)

View →

Feb 17, 2026Feb 17 9:40 PMRANDAL SCOTT
Proposed Sale
20,000$75.25$1.5M—

View →

Feb 17, 2026Feb 17 9:06 PMTHOMAS TRIMARCHI
Proposed Sale
13,600$74.72$1.0M—

View →

Feb 11, 2026Feb 12 9:39 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$71.78$2.9M4,478,447(I)

View →

Feb 10, 2026Feb 12 9:39 PMNeil KumarDirector, Chief Executive Officer
Sale
40,000$71.94$2.9M4,498,447(I)

View →

Jan 8, 2026Jan 8 9:23 PMKUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018
Proposed Sale
120,000$74.27$8.9M—

View →

Jan 8, 2026Jan 8 9:23 PMKUMAR HALDEA FAMILY IRREVOCABLE TRUST
Proposed Sale
100,000$74.27$7.4M—

View →

Dec 15, 2025Dec 15 9:23 PMNEIL KUMAR
Proposed Sale
30,011$75.15$2.3M—

View →

Nov 20, 2025Nov 20 9:20 PMNEIL KUMAR
Proposed Sale
26,156$65.54$1.7M—

View →

Nov 18, 2025Nov 18 9:06 PMANDREW W LO
Proposed Sale
55,000$65.69$3.6M—

View →

Nov 17, 2025Nov 17 10:24 PMANDREW W LO
Proposed Sale
40,599$66.67$2.7M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 16, 2026Aug 18 10:02 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,217—91,274(D)

View →

Jul 9, 2026Jul 13 8:41 PMAndrea EllisDirector
Option Exercise
17,167$16.7517,167(D)

View →

Jul 9, 2026Jul 13 8:40 PMJennifer E. CookDirector
Option Exercise
148,589$29.000(D)

View →

Jun 24, 2026Jun 24 10:06 PMJennifer E. CookDirector
Option Exercise
37,167$16.7517,167(D)

View →

Jun 22, 2026Jun 24 10:06 PMJennifer E. CookDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMHannah ValantineDirector
Option Exercise
2,808$41.735,617(D)

View →

Jun 22, 2026Jun 24 10:06 PMLo AndrewDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMCharles J HomcyDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:06 PMEric AguiarDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDANIELS RONALD JDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAndrea EllisDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMHassan FredDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMJames C MomtazeeDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMFrank MccormickDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMDouglas A. DachilleDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 22, 2026Jun 24 10:05 PMAli J. SatvatDirector
Grant/Award
5,277$68.925,277(D)

View →

Jun 15, 2026Jun 17 8:45 PMJennifer E. CookDirector
Option Exercise
83,088$16.7534,334(D)

View →

May 16, 2026May 19 8:27 PMNeil KumarDirector, Chief Executive Officer
Option Exercise
71,215—97,794(D)

View →

May 15, 2026May 19 8:25 PMRandal W. ScottDirector
Option Exercise
10,000$16.7521,501(D)

View →

Page 1 of 2

Next →